The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1
Open accessAbstract
(-)-Epigallocatechin-3-gallate (EGCG) has been reported to affect many cellular regulatory pathways. This study aims to determine whether EGCG could target microRNA (miRNA), one of the mechanisms for cells to achieve subtle change in multiple targets. We found that, in both human and mouse lung cancer cells in culture, EGCG specifically upregulated the expression of miR-210, a major miRNA regulated by HIF-1α. Furthermore, we found that overexpression of miR-210 led to reduced cell proliferation rate and anchorage-independent growth as well as reduced sensitivity to EGCG. On the mechanisms of miR-210 regulation by EGCG, we demonstrated that the regulation was mediated through the hypoxia-response element in miR-210 promoter. Consistently, the upregulation of miR-210 was found to be correlated with the stabilized HIF-1α in lung cancer cell lines after EGCG treatment. This EGCG-induced stabilization of HIF-1α was further shown by the stabilization of HA-tagged HIF-1α but not the P402A/P564A-mutated HIF-1α by EGCG, suggesting that EGCG targets the oxygen-dependent degradation (ODD) domain. Direct evidence was obtained by affinity binding assay showing that EGCG specifically binds HIF-1α with a K(d) = 3.47 μM. This result suggests that EGCG binding interferes with the hydroxylation of key Pro residues in the ODD domain, preventing HIF-1α from the Pro hydroxylation-dependent ubiquitination and subsequent proteosome-mediated degradation. In summary, our results demonstrated, for the first time, the elevation of miR-210 by EGCG in lung cancer cell lines and this is mediated by the stabilization of HIF-1α. This event contributes to the anticancer activity of EGCG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2641 · Cited by 995
Self-citationTargeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3636 · Cited by 820
microPrimer: the biogenesis and function of microRNA
Du, T., & Zamore, P. D. (2005) · Development · doi:10.1242/dev.02070 · Cited by 813
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
Baxter, N. J., Lilley, T. H., Haslam, E., & Williamson, M. P. (1997) · Biochemistry · doi:10.1021/bi9700328 · Cited by 682
HIF-1α induces cell cycle arrest by functionally counteracting Myc
Koshiji, M., Kageyama, Y., Pete, E. A., Horikawa, I., Barrett, J. C., & Huang, L. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600196 · Cited by 652
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Hypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
Lu, Y., Thomson, J. M., Wong, H. Y. F., Hammond, S. M., & Hogan, B. L. M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.08.007 · Cited by 484
Dicer1 functions as a haploinsufficient tumor suppressor
Kumar, M. S., Pester, R. E., Chen, C. Y., Lane, K., Chin, C., Lu, J., Kirsch, D. G., Golub, T. R., & Jacks, T. (2009) · Genes & Development · doi:10.1101/gad.1848209 · Cited by 442
Bruick, R. K. (2003) · Genes & Development · doi:10.1101/gad.1145503 · Cited by 440
Dicer function is essential for lung epithelium morphogenesis
Harris, K. S., Zhang, Z., McManus, M. T., Harfe, B. D., & Sun, X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510839103 · Cited by 424
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., Cordon-Cardo, C., Celeste Simon, M., Rafii, S., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature05029 · Cited by 378
Hou, Z., Sang, S., You, H., Lee, M.-J., Hong, J., Chin, K.-V., & Yang, C. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0480 · Cited by 298
Self-citationLi, G.-X., Chen, Y.-K., Hou, Z., Xiao, H., Jin, H., Lu, G., Lee, M.-J., Liu, B., Guan, F., Yang, Z., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq039 · Cited by 237
Self-citationMURRAY, N. J., WILLIAMSON, M. P., LILLEY, T. H., & HASLAM, E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18574.x · Cited by 229
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 213
Tsuchiya, S., Fujiwara, T., Sato, F., Shimada, Y., Tanaka, E., Sakai, Y., Shimizu, K., & Tsujimoto, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170852 · Cited by 203
Yan, Q., Bartz, S., Mao, M., Li, L., & Kaelin, W. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01514-06 · Cited by 193
Uncovering Growth-Suppressive MicroRNAs in Lung Cancer
Liu, X., Sempere, L. F., Galimberti, F., Freemantle, S. J., Black, C., Dragnev, K. H., Ma, Y., Fiering, S., Memoli, V., Li, H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1355 · Cited by 173
Zhang, Q., Tang, X., Lu, Q., Zhang, Z., Rao, J., & Le, A. D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0490 · Cited by 168
Chung, J. Y., Park, J. O., Phyu, H., Dong, Z., & Yang, C. S. (2001) · The FASEB Journal · doi:10.1096/fj.01-0031fje · Cited by 160
Self-citationLiang, G., Tang, A., Lin, X., et al. (2010) · PubMed · Cited by 150
HIF-2α deletion promotes Kras-driven lung tumor development
Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 141
Shimizu, M., Shirakami, Y., Sakai, H., Yasuda, Y., Kubota, M., Adachi, S., Tsurumi, H., Hara, Y., & Moriwaki, H. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.036 · Cited by 132
MicroRNAs and Cellular Phenotypy
Kosik, K. S. (2010) · Cell · doi:10.1016/j.cell.2010.09.008 · Cited by 125
Shim, J., Choi, H. S., Pugliese, A., Lee, S., Chae, J., Choi, B. Y., Bode, A. M., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802200200 · Cited by 112
Sumiyoshi, Y., Kakeji, Y., Egashira, A., Mizokami, K., Orita, H., & Maehara, Y. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2382 · Cited by 109
Zhou, Y., Kim, Y.-P., Li, X., Baerson, S. R., Agarwal, A. K., Hodges, T. W., Ferreira, D., & Nagle, D. G. (2004) · Journal of Natural Products · doi:10.1021/np040140c · Cited by 93
Canon, F., Giuliani, A., Paté, F., & Sarni‐Manchado, P. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3997-9 · Cited by 90
Weinreb, O., Amit, T., & Youdim, M. B. H. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.011 · Cited by 79
Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells
Thomas, R., & Kim, M. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.114 · Cited by 76
Lü, G., Xiao, H., You, H., Lin, Y., Jin, H., Snagaski, B., & Yang, C. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1860 · Cited by 67
Self-citationWang, H., Fang, R., Cho, J., Libermann, T. A., & Oettgen, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401356200 · Cited by 52
Self-citationRhoH plays distinct roles in T-cell migrations induced by different doses of SDF1α
Wang, H., Zeng, X., Fan, Z., & Lim, B. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.02.005 · Cited by 16
Self-citation
Cited by
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Epigenetics: The link between nature and nurture
Tammen, S. A., Friso, S., & Choi, S.-W. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.018 · Cited by 494
Liu, W., Li, L., Rong, Y., Qian, D., Chen, J., Zhou, Z., Luo, Y., Jiang, D., Cheng, L., Zhao, S., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.12.020 · Cited by 466
Gan, R.-Y., Li, H.-B., Sui, Z.-Q., & Corke, H. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1231168 · Cited by 438
Metadata
- Authors
- Wang, H., Bian, S., & Yang, C. S.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-28
- Volume
- 32
- Issue
- 12
- Pages
- 1881-1889
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2115394717
- Cited by
- 261
- References
- 50
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.